Why is Symbiox Investme falling/rising?

As of 23-Jun, Symbiox Investment & Trading Co Ltd is experiencing a decline in its stock price, currently at 2.90, reflecting a decrease of 0.17 or 5.54%. The stock has underperformed its sector today by 6.07%, and it is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Over the past week, the stock has seen a significant drop of 12.39%, while its year-to-date performance shows a steep decline of 46.49%. Despite a positive return of 6.62% over the past year, the company is facing operating losses and weak long-term fundamental strength, with a poor growth rate of operating profit at 3.89%. The recent financial results indicate the lowest quarterly performance metrics, contributing to the stock's negative sentiment among investors.
In the broader market context, the Sensex has shown a slight increase of 0.12% over the past week, contrasting sharply with Symbiox's significant decline. This disparity highlights the stock's struggles relative to the overall market performance. The rising investor participation, indicated by an 84.87% increase in delivery volume, suggests some interest, but the company's weak fundamentals and high valuation concerns, evidenced by a low return on equity and a price-to-book ratio of 0.3, continue to weigh heavily on investor confidence. Overall, the combination of poor financial performance and unfavorable market conditions is driving the stock's downward trajectory.